NVNO enVVeno Medical Corporation - Common Stock
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Jul 30, 2026
$8.10
· of 52w range
· above low
· to high
$7.0152w low
$35.1852w high
Market Cap (MRQ)
$5M
P/E
-0.2
EPS
$-33.06
your badges
52W Range
$7–$35
Analyst Rating
STRONG BUY
Price Target
$30
P/E
-0.2
ROE
-64.7%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
NVNO Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$8.10
Market Cap (MRQ)
$5M
P/E
-0.2
EPS
$-33.06
ROE
-64.7%
52W Range
$7–$35
NVNO Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Jan. 20, 2026 | 1-for-35 | Reverse |
| Nov. 30, 2020 | 1-for-25 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue·2017-12-31 → 2019-12-31
EPS$-33.062022-12-31 → 2025-12-31
Free Cash Flow$-16M2018-12-31 → 2025-12-31
Net margin·2018-12-31 → 2022-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | NVNO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -0.25Y avg ≈-1.3 | ≈-1.3 | · | · | |
| P/S | 28.45Y avg ≈226.8 | ≈226.8 | 2.7 | Undervalued | |
| P/B (MRQ) | 0.35Y avg ≈1.0 | ≈1.0 | 1.2 | Undervalued | |
| Price / FCF | -0.35Y avg ≈-2.5 | ≈-2.5 | · | · | |
| Price / Cash Flow | -0.35Y avg ≈-2.5 | ≈-2.5 | · | · | |
| Price / Tangible Book | 0.25Y avg ≈1.0 | ≈1.0 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | NVNO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -52.3%5Y avg ≈-50.2% | ≈-50.2% | -106.2% | Top tier | |
| ROE | -64.7%5Y avg ≈-60.1% | ≈-60.1% | -151.8% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | NVNO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 11.75Y avg ≈23.6 | ≈23.6 | 4.6 | Strong liquidity | |
| Quick Ratio | 13.35Y avg ≈23.3 | ≈23.3 | 2.2 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
9.9%
Next Report
Oct 28, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Jul 29, 2026 | $-5.37 | $-4.78 | -12.3% |
| Sept. 30, 2025 | $-8.05 | $-10.71 | 24.8% | |
| June 30, 2025 | $-11.55 | $-10.00 | -15.5% | |
| March 31, 2025 | $-7.70 | $-12.14 | 36.6% | |
| Dec. 31, 2024 | $-10.50 | $-12.49 | 16.0% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $31.2K | $186.6K | $422.1K | |
| Cost of Revenue | · | · | · | · | · | · | · | · | $419.7K | |
| Gross Profit | · | · | · | · | · | · | · | $186.6K | $2.5K | |
| R&D Expense | $10M | $12M | $14M | $10M | $6M | $4M | $2M | $1M | $649.7K | |
| SG&A Expense | $11M | $12M | $12M | $15M | $11M | $5M | $5M | $6M | $5M | |
| Operating Income | $-21M | $-24M | $-25M | $-25M | $-17M | $-9M | $-8M | $-8M | $-6M | |
| Other Non-op | $1M | $2M | $2M | $263.0K | $33.0K | $-215.9K | $-49.9K | $5M | $2M | |
| Pretax Income | $-19M | $-22M | · | · | · | · | · | · | · | |
| Net Income | $-19M | $-22M | $-24M | $-25M | $-17M | $-9M | $-8M | $-13M | $-8M | |
| EPS (Basic) | $-33.06 | $-44.53 | $-1.91 | $-2.20 | $-1.90 | · | · | · | · | |
| EPS (Diluted) | $-33.06 | $-44.53 | $-1.91 | $-2.20 | · | · | · | · | · | |
| Shares (Basic) | 589,000 | 490,000 | 12,301,000 | 11,230,000 | 8,680,000 | · | · | · | · | |
| Shares (Diluted) | 589,000 | 490,000 | 12,301,000 | 11,230,000 | · | · | · | · | · | |
| EBITDA | $-21M | $-24M | $-25M | $-25M | · | $-9M | $-8M | $-8M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $2M | $4M | $5M | $55M | $9M | $1M | $3M | $77.7K | |
| Short-term Investments | $25M | $41M | $43M | $34M | · | · | · | · | · | |
| Receivables | · | · | · | · | · | · | · | $32.0K | $35.2K | |
| Prepaid Expense | $614.0K | $581.0K | $511.0K | $392.0K | $312.0K | $234.5K | $116.6K | $64.3K | $57.5K | |
| Current Assets | $29M | $44M | $47M | $39M | $55M | $10M | $1M | $3M | $170.4K | |
| PP&E (Net) | $51.0K | $182.0K | $334.0K | $521.0K | $618.0K | $399.0K | $344.0K | $26.2K | $23.8K | |
| PP&E (Gross) | $1M | $1M | $1M | $1M | $1M | $886.9K | $737.1K | $373.2K | $386.8K | |
| Accum. Depreciation | $1M | $1M | $1M | $849.0K | $637.0K | $487.9K | $393.1K | $347.1K | $362.9K | |
| Intangibles | · | · | · | · | · | · | · | $666.5K | $1M | |
| Total Assets | $30M | $45M | $49M | $42M | $58M | $11M | $3M | $4M | $2M | |
| Accounts Payable | $358.0K | $1M | $1M | $1M | $560.0K | $1M | $1M | $1M | $1M | |
| Accrued Liabilities | · | · | · | · | · | $1M | $333.4K | $412.9K | $903.6K | |
| Short-term Debt | · | · | · | · | · | $312.7K | · | · | $275.0K | |
| Current Liabilities | $2M | $2M | $1M | $2M | $2M | $3M | $2M | $2M | · | |
| Capital Leases | $310.0K | $700.0K | $1M | $1M | $2M | $253.7K | $567.9K | · | · | |
| Total Liabilities | $2M | $3M | $2M | $3M | $3M | $3M | $2M | $2M | $8M | |
| Total Debt | · | · | · | · | · | $312.7K | · | · | · | |
| Common Stock | · | · | · | · | · | $25 | $7 | $117 | $61 | |
| Paid-in Capital | $198M | $194M | $176M | $145M | $136M | $72M | $57M | $51M | $24M | |
| Retained Earnings | $-171M | $-152M | $-130M | $-107M | $-82M | $-65M | $-56M | $-49M | $-36M | |
| Stockholders' Equity | $27M | $42M | $46M | $39M | $54M | $7M | $989.9K | $2M | $-11M | |
| Liabilities + Equity | $30M | $45M | $49M | $42M | $58M | $11M | $3M | $4M | $2M | |
| Shares Outstanding | 656,000 | 501,000 | 13,317,000 | 9,472,000 | 9,470,000 | 2,541,529 | 717,274 | 11,722,647 | 6,133,678 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $136.0K | $189.0K | $220.0K | $212.0K | $149.0K | $97.5K | $123.7K | $133.4K | $139.2K | |
| Stock-based Comp | $3M | $4M | $5M | $9M | $6M | $881.2K | $942.0K | $2M | $878.4K | |
| Amort. of Intangibles | · | · | · | · | · | · | $77.6K | $111.9K | $123.3K | |
| Operating Cash Flow | $-16M | $-17M | $-19M | $-16M | $-12M | $-8M | $-6M | $-6M | $-4M | |
| CapEx | $5.0K | $37.0K | $33.0K | $115.0K | $368.0K | $180.3K | $363.9K | $12.4K | $10.9K | |
| Investing Cash Flow | $16M | $1M | $-8M | $-35M | $-368.0K | $-180.3K | $-363.9K | $-12.4K | $165.3K | |
| Stock Issued | $782.0K | · | $26M | · | $57M | $12M | · | · | · | |
| Net Stock Activity | $782.0K | · | $26M | · | · | · | · | · | · | |
| Financing Cash Flow | $1M | $14M | $26M | · | $58M | $15M | $6M | $9M | $4M | |
| Net Change in Cash | $1M | $-2M | $-935.0K | $-50M | $45M | $7M | $-623.4K | $3M | $21.2K | |
| Free Cash Flow | $-16M | $-17M | $-19M | $-16M | · | $-8M | $-6M | $-6M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 100.0% | · | |
| Operating Margin | · | · | · | -15485.7% | · | 244320.0% | -24566.5% | -4210.5% | · | |
| Net Margin | · | · | · | -15322.4% | · | 244329.7% | -24406.7% | -6991.5% | · | |
| EBITDA Margin | · | · | · | -15485.7% | · | 244320.0% | -24566.5% | -4210.5% | · | |
| ROA | -52.3% | -46.6% | -52.1% | -49.7% | · | -130.8% | -218.1% | -451.8% | · | |
| ROE | -64.7% | -48.7% | -66.1% | -60.6% | · | -153.6% | -374.4% | -467.6% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.6 | 20.9 | 34.2 | 25.8 | · | 3.0 | 0.8 | · | · | |
| Quick Ratio | 13.3 | 20.6 | 33.9 | 25.5 | · | 2.9 | 0.7 | · | · | |
| Debt / Equity | · | · | · | · | · | 0.0 | · | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | · | -0.0 | 0.0 | 0.1 | · | |
| Receivables Turnover | · | · | · | · | · | · | · | 5.6 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $41.36 | $2.40 | $3.47 | $4.09 | · | $2.79 | $0.06 | $0.17 | · | |
| Cash Flow / Share | $-26.43 | $-0.98 | $-1.53 | · | · | · | · | · | · | |
| Cash / Share | $4.67 | $0.10 | $0.27 | $0.48 | · | $3.67 | $0.07 | $0.23 | · | |
| EPS (TTM) | $-33.06 | $-44.53 | $-1.91 | $-2.20 | · | · | · | · | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | 747.4% | 408.2% | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $187.3K | $187.3K | $187.3K | $187.3K | $187.3K | $187.3K | $31.2K | $186.6K | · | |
| Net Income TTM | $-19M | $-22M | $-24M | $-25M | $-17M | $-9M | $-8M | $-13M | · | |
| Market Cap | $210.6K | $53M | $68M | $48M | · | $22M | $247M | $432M | · | |
| Enterprise Value | · | · | · | · | · | $13M | · | · | · | |
| P/E | -0.0 | -0.1 | -2.7 | -2.3 | · | · | · | · | · | |
| P/S | 1.1 | 282.7 | 365.4 | 257.9 | · | 117.4 | 7891.8 | 2317.2 | · | |
| P/B | 0.0 | 1.3 | 1.5 | 1.2 | · | 3.1 | 249.1 | 212.3 | · | |
| P / Tangible Book | 0.0 | 1.3 | 1.5 | 1.2 | 1.1 | 3.1 | · | · | · | |
| P / Cash Flow | -0.0 | -3.1 | -3.6 | -3.1 | · | -2.9 | -41.8 | -68.0 | · | |
| P / FCF | -0.0 | -3.1 | -3.6 | -3.1 | · | -2.8 | -39.4 | -67.9 | · | |
| EV / EBITDA | · | · | · | · | · | -1.4 | · | · | · | |
| EV / FCF | · | · | · | · | · | -1.6 | · | · | · | |
| EV / Revenue | · | · | · | · | · | 69.2 | · | · | · | |
| Earnings Yield | -10299.1% | -1474.5% | -37.2% | -43.1% | · | · | · | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $2M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $4M | $2M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | |
| Operating Income | $-4M | $-4M | $-4M | $-5M | $-7M | $-5M | $-7M | $-6M | $-5M | $-6M | $-6M | $-5M | $-7M | $-7M | $-6M | $-6M | |
| Other Non-op | $196.0K | $213.0K | $277.0K | $344.0K | $355.0K | $451.0K | $470.0K | $528.0K | $498.0K | $511.0K | $629.0K | $348.0K | $340.0K | $405.0K | $280.0K | $54.0K | |
| Net Income | $-4M | $-4M | $-4M | $-5M | $-7M | $-5M | $-6M | $-6M | $-5M | $-5M | $-6M | $-5M | $-6M | $-6M | $-6M | $-6M | |
| EPS (Basic) | $-5.37 | $-5.89 | $-32.28 | $-0.23 | $-11.52 | $-7.75 | $-43.56 | $-0.35 | $-0.31 | $-0.31 | $-0.31 | $-0.45 | $-0.58 | $-0.57 | $-0.56 | $-0.54 | |
| EPS (Diluted) | $-5.37 | $-5.89 | $-32.28 | $-0.23 | $-11.52 | $-7.75 | $-43.56 | $-0.35 | $-0.31 | $-0.31 | $-0.31 | $-0.45 | $-0.58 | $-0.57 | $-0.55 | $-0.54 | |
| Shares (Basic) | 671,000 | 654,000 | · | 20,155,000 | 581,000 | 581,000 | · | 16,067,000 | 16,067,000 | 16,057,000 | · | 11,231,000 | 11,231,000 | 11,231,000 | · | 11,229,000 | |
| Shares (Diluted) | 671,000 | 654,000 | · | 20,155,000 | 581,000 | 581,000 | · | 16,067,000 | 16,067,000 | 16,057,000 | · | 11,231,000 | 11,231,000 | 11,231,000 | · | 11,229,000 | |
| EBITDA | $-4M | $-4M | · | $-5M | $-7M | $-5M | · | $-6M | $-5M | $-6M | · | $-5M | $-7M | $-7M | · | $-6M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $3M | $3M | $2M | $2M | $3M | $2M | $18M | $2M | $2M | $4M | $5M | $5M | $2M | $5M | $3M | |
| Short-term Investments | $19M | $22M | $25M | $29M | $33M | $36M | $41M | $30M | $37M | $41M | $43M | $21M | $25M | $32M | $34M | $37M | |
| Prepaid Expense | $596.0K | $559.0K | $614.0K | $547.0K | $462.0K | $538.0K | $581.0K | $672.0K | $469.0K | $306.0K | $511.0K | $520.0K | $352.0K | $312.0K | $392.0K | $381.0K | |
| Current Assets | $22M | $25M | $29M | $31M | $36M | $39M | $44M | $49M | $40M | $43M | $47M | $26M | $30M | $35M | $39M | $41M | |
| PP&E (Net) | $78.0K | $16.0K | $51.0K | $82.0K | $113.0K | $142.0K | $182.0K | $218.0K | $252.0K | $289.0K | $334.0K | $385.0K | $438.0K | $472.0K | $521.0K | $566.0K | |
| PP&E (Gross) | · | · | $1M | · | · | $1M | $1M | · | · | $1M | $1M | · | · | $1M | $1M | · | |
| Accum. Depreciation | · | · | $1M | · | · | $1M | $1M | · | · | $1M | $1M | · | · | $903.0K | $849.0K | · | |
| Total Assets | $23M | $26M | $30M | $32M | $37M | $41M | $45M | $50M | $41M | $45M | $49M | $28M | $32M | $37M | $42M | $45M | |
| Accounts Payable | $540.0K | $813.0K | $358.0K | $2M | $3M | $1M | $1M | $2M | $1M | $1M | $1M | $2M | $2M | $847.0K | $1M | $501.0K | |
| Current Liabilities | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | $2M | $1M | |
| Capital Leases | $103.0K | $207.0K | $310.0K | $505.0K | $505.0K | $609.0K | $700.0K | $791.0K | $882.0K | $973.0K | $1M | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $2M | $2M | $2M | $3M | $4M | $2M | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $2M | $3M | $3M | |
| Paid-in Capital | $199M | $199M | $198M | $197M | $196M | $195M | $194M | $193M | $178M | $177M | $176M | $149M | $148M | $147M | $145M | $143M | |
| Retained Earnings | $-179M | $-175M | $-171M | $-168M | $-163M | $-156M | $-152M | $-146M | $-140M | $-135M | $-130M | $-124M | $-119M | $-113M | $-107M | $-100M | |
| Stockholders' Equity | $21M | $24M | $27M | $29M | $33M | $38M | $42M | $47M | $38M | $42M | $46M | $25M | $29M | $34M | $39M | $43M | |
| Liabilities + Equity | $23M | $26M | $30M | $32M | $37M | $41M | $45M | $50M | $41M | $45M | $49M | $28M | $32M | $37M | $42M | $45M | |
| Shares Outstanding | 673,000 | 656,000 | 656,000 | 20,216,000 | 19,247,000 | 17,536,000 | 501,000 | 17,536,000 | 13,330,000 | 13,330,000 | 13,317,000 | 9,472,000 | 9,472,000 | 9,472,000 | 9,472,000 | 9,472,000 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | $31.0K | $31.0K | $31.0K | $34.0K | $40.0K | $40.0K | $43.0K | $51.0K | $55.0K | $55.0K | $56.0K | $55.0K | $54.0K | $54.0K | $54.0K | |
| Stock-based Comp | $397.0K | $467.0K | $637.0K | $688.0K | $1M | $651.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | |
| Operating Cash Flow | $-4M | $-3M | $-3M | $-4M | $-4M | $-4M | $-5M | $-4M | $-4M | $-4M | $-5M | $-4M | $-5M | $-5M | $-4M | $-4M | |
| CapEx | · | · | $0 | $0 | · | · | $4.0K | $9.0K | $14.0K | $10.0K | $4.0K | $3.0K | $21.0K | $5.0K | $9.0K | $14.0K | |
| Investing Cash Flow | $4M | $3M | $4M | $4M | $3M | $5M | $-11M | $6M | $4M | $2M | $-22M | $4M | $7M | $3M | $6M | $-2M | |
| Financing Cash Flow | · | · | $782.0K | · | · | · | $0 | $14M | $0 | $46.0K | · | · | · | · | · | · | |
| Net Change in Cash | $244.0K | $-468.0K | $2M | $-500.0K | $-893.0K | $1M | $-16M | $16M | $66.0K | $-1M | $-1M | $232.0K | $2M | $-2M | $2M | $-6M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-4M | · | · | · | $-5M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -12.2% | -11.6% | · | -11.0% | -17.3% | -10.5% | · | -14.4% | -13.6% | -12.3% | · | -13.6% | -15.8% | -14.1% | · | -11.7% | |
| ROE | -13.4% | -12.4% | · | -11.8% | -18.7% | -11.2% | · | -15.6% | -14.7% | -13.1% | · | -14.8% | -17.2% | -15.0% | · | -12.1% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.7 | 11.9 | · | 13.1 | 11.8 | 23.8 | · | 22.0 | 23.3 | 29.1 | · | 12.9 | 14.6 | 29.6 | · | 31.2 | |
| Quick Ratio | 11.4 | 11.6 | · | 12.9 | 11.7 | 23.4 | · | 21.7 | 23.0 | 28.9 | · | 12.7 | 14.4 | 29.3 | · | 30.9 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $30.71 | $36.20 | · | $1.46 | $1.72 | $2.18 | · | $2.70 | $2.88 | $3.18 | · | $2.63 | $3.04 | $3.60 | · | $4.50 | |
| Cash Flow / Share | · | $-4.95 | · | · | · | $-0.20 | · | · | · | $-0.22 | · | · | · | · | · | · | |
| Cash / Share | $4.22 | $3.96 | · | $0.08 | $0.11 | $0.17 | · | $1.02 | $0.18 | $0.17 | · | $0.52 | $0.50 | $0.24 | · | $0.31 | |
| EPS (TTM) | $-43.77 | $-49.92 | · | $-63.06 | $-63.18 | $-51.97 | · | $-1.28 | $-1.38 | $-1.65 | · | $-2.15 | $-2.24 | $-2.29 | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-16M | $-19M | · | $-22M | $-23M | $-21M | · | $-21M | $-21M | $-22M | · | $-24M | $-25M | $-26M | · | $-27M | |
| Market Cap | $7M | $7M | · | $18M | $77M | $46M | · | $59M | $70M | $73M | · | $51M | $29M | $44M | · | $59M | |
| P/E | -0.2 | -0.2 | · | -0.5 | -2.2 | -1.8 | · | -91.9 | -133.2 | -115.4 | · | -87.7 | -48.1 | -71.5 | · | · | |
| P/B | 0.3 | 0.3 | · | 0.6 | 2.3 | 1.2 | · | 1.2 | 1.8 | 1.7 | · | 2.0 | 1.0 | 1.3 | · | 1.4 | |
| P / Tangible Book | 0.3 | 0.3 | · | 0.6 | 2.3 | 1.2 | · | 1.2 | 1.8 | 1.7 | · | 2.0 | 1.0 | 1.3 | · | 1.4 | |
| P / Cash Flow | · | -2.1 | · | · | · | -11.5 | · | · | · | -20.4 | · | · | · | -8.7 | · | · | |
| Earnings Yield | -408.7% | -492.8% | · | -198.9% | -45.2% | -56.5% | · | -1.1% | -0.75% | -0.87% | · | -1.1% | -2.1% | -1.4% | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Operating Margin % | · | · | · | -15485.7% | · |
| Net Income | $-19M | $-22M | $-24M | $-25M | $-17M |
| Diluted EPS | $-33.06 | $-44.53 | $-1.91 | $-2.20 | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 13.6 | 20.9 | 34.2 | 25.8 | · |
| Quick Ratio | 13.3 | 20.6 | 33.9 | 25.5 | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-16M | $-17M | $-19M | $-16M | · |
Institutional owners (13F) 20 filers · $1.1M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
20
Value held
$1.1M
New positions
2
Exited positions
3
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 2 | 3 | 0 | 6 | · |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair. Change vs prior quarter not shown: filer coverage differs too much between these two quarters for a reliable comparison.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $387,338 | 36,166 | 36.16% | Shares |
| CM Management, LLC | $382,497 | 35,714 | 35.71% | Shares |
| VANGUARD GROUP INC | $96,058 | 299,246 | 8.97% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $67,397 | 6,287 | 6.29% | Shares |
| JPMORGAN CHASE & CO | $59,111 | 5,208 | 5.52% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $23,412 | 2,184 | 2.19% | Shares |
| WOLVERINE TRADING, LLC | $17,204 | 18,339 | 1.61% | Shares |
| Westside Investment Management, Inc. | $16,332 | 1,525 | 1.52% | Shares |
| Mirae Asset Global Investments Co., Ltd. | $5,773 | 539 | 0.54% | Shares |
| TWO SIGMA ADVISERS, LP | $4,491 | 14,000 | 0.42% | Shares |
| BlackRock, Inc. | $4,434 | 414 | 0.41% | Shares |
| Tower Research Capital LLC (TRC) | $3,545 | 331 | 0.33% | Shares |
| WELLS FARGO & COMPANY/MN | $1,221 | 114 | 0.11% | Shares |
| Vanguard Global Advisers, LLC | $825 | 77 | 0.08% | Shares |
| CIBC Private Wealth Group LLC | $779 | 860 | 0.07% | Shares |
| MORGAN STANLEY | $632 | 59 | 0.06% | Shares |
| OSAIC HOLDINGS, INC. | $74 | 7 | 0.01% | Shares |
| BARCLAYS PLC | $21 | 2 | 0.00% | Shares |
| GROUP ONE TRADING LLC | $21 | 2 | 0.00% | Shares |
| UBS Group AG | $11 | 1 | 0.00% | Shares |
Activists & 5%+ owners 3 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Braeden Lichti, Northstrive Fund II LP ×2 filings | Sept. 15, 2026 | 0.00% | Amendment | · | SEC |
| Northstrive Fund II LP, Braeden Lichti | Feb. 20, 2026 | 5.05% | Initial filing | Passive investment | SEC |
| Fatboy Capital, LP, SeaCap Management, LLC, David A. Jenkins ×2 filings | Dec. 18, 2020 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 12 insiders · 6 officers · 6 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Robert Andrew Berman | Chief Executive Officer | Dec. 16, 2025 J | 222,236 | 0 | 0 | $0 |
| Jennifer Bright | Chief Financial Officer | May 19, 2025 A | · | 0 | 0 | $0 |
| Craig Glynn | Chief Financial Officer | Dec. 5, 2023 A | 50,000 | 0 | 0 | $0 |
| Hamed Alavi | Chief Technology Officer | Dec. 16, 2025 J | 0 | 0 | 0 | $0 |
| Marc H. Glickman | SVP & Chief Medical Officer | Dec. 16, 2025 J | 101,600 | 0 | 0 | $0 |
| Benedict Broennimann | Chief Medical Officer, OUS | Nov. 27, 2018 A | 437,778 | 0 | 0 | $0 |
| Francis Duhay | Director | Sept. 11, 2026 S | 2,351 | 0 | 4 | $-4,942 |
| Robert Gray | Director | Dec. 11, 2025 A | 11,155 | 0 | 0 | $0 |
| Sanjay Shrivastava | Director | Dec. 11, 2025 A | 9,288 | 0 | 0 | $0 |
| Matthew Jenusaitis | Director | Dec. 11, 2025 A | 16,545 | 0 | 0 | $0 |
| Marcus W. Robins | Director | Nov. 27, 2018 A | 29,183 | 0 | 0 | $0 |
| Biodyne Holding, S.A. | · | Aug. 21, 2020 S | 1,405,433 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0.00% | 6,287 SH | Aug. 19, 2026 | Daily |
NVNO Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
BUY
Median target
$30.00
+270.4%
3 42.9%
Strong Buy
3 42.9%
Buy
1 14.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
1 analysts · 2026-10-04Mean target $30.00 +270.4%
Low$30.00
Mean$30.00
High$30.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| NVNO | $210.6K | -0.0 | · | · | -64.7% | · |
| NDRA | $5M | -0.5 | · | · | -376.5% | · |
| CODX | $11M | -0.1 | -84.1% | -7533.6% | -151.8% | 64.3% |
| AMIX | · | · | · | · | · | · |
| INBS | $7M | -0.3 | 38.1% | -294.9% | -292.2% | 48.6% |
| NXL | $11M | -1.1 | 78.8% | -2725.8% | -169.3% | 79.7% |
| IVF | · | -0.0 | 4.7% | · | · | · |
| XAIR | $8M | -0.2 | 107.3% | -433.0% | -337.4% | 3.3% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Jul 30, 2026